1. Home
  2. ICU
  3. ICU News

Latest SeaStar Medical Holding Corporation (ICU) News on February 23, 2025

SeaStar Medical Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market
ICU

GlobeNewswire

20 days ago

SeaStar Medical Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market

SeaStar Medical Announces $6 Million Registered Direct Offering Priced At-the-Market
ICU

GlobeNewswire

23 days ago

SeaStar Medical Announces $6 Million Registered Direct Offering Priced At-the-Market

SeaStar Medical Adds Fifth Hospital Customer for QUELIMMUNE
ICU

GlobeNewswire

a month ago

SeaStar Medical Adds Fifth Hospital Customer for QUELIMMUNE

Mayo Clinic joins SeaStar Medical for acute kidney injury trial
ICU

Medical Device Network

a month ago

Mayo Clinic joins SeaStar Medical for acute kidney injury trial

SeaStar Medical Activates 15th Site for its Adult Acute Kidney Injury Pivotal Trial
ICU

GlobeNewswire

a month ago

SeaStar Medical Activates 15th Site for its Adult Acute Kidney Injury Pivotal Trial

SeaStar Medical says FDA approves feasibility study with SCD-ADULT
ICU

TipRanks

a month ago

SeaStar Medical says FDA approves feasibility study with SCD-ADULT

ICU

MT Newswires

a month ago

SeaStar Medical Says FDA Approved Study on Selective Cytopheretic Device in Cardiorenal Syndrome

FDA Approves Feasibility Study with SeaStar Medical’s Selective Cytopheretic Device in Adults with Cardiorenal Syndrome
ICU

GlobeNewswire

a month ago

FDA Approves Feasibility Study with SeaStar Medical’s Selective Cytopheretic Device in Adults with Cardiorenal Syndrome

SeaStar Medical Begins Shipping QUELIMMUNE to a Fourth Hospital Customer
ICU

GlobeNewswire

a month ago

SeaStar Medical Begins Shipping QUELIMMUNE to a Fourth Hospital Customer

SeaStar Medical Activates 14th Hospital for its Adult AKI Pivotal Trial
ICU

GlobeNewswire

2 months ago

SeaStar Medical Activates 14th Hospital for its Adult AKI Pivotal Trial

SeaStar Medical Projects Multibillion-Dollar Market Potential for its Selective Cytopheretic Device in Initial Target Indications
ICU

GlobeNewswire

2 months ago

SeaStar Medical Projects Multibillion-Dollar Market Potential for its Selective Cytopheretic Device in Initial Target Indications

SeaStar Medical to Hold Business Update Conference Call on December 11, 2024
ICU

GlobeNewswire

3 months ago

SeaStar Medical to Hold Business Update Conference Call on December 11, 2024

SeaStar Medical Activates Sentara Norfolk General Hospital and Provides Enrollment Update in Adult AKI Pivotal Trial
ICU

GlobeNewswire

3 months ago

SeaStar Medical Activates Sentara Norfolk General Hospital and Provides Enrollment Update in Adult AKI Pivotal Trial

SeaStar Medical to Present at Noble Capital Markets’ NobleCon20 on December 4, 2024
ICU

GlobeNewswire

3 months ago

SeaStar Medical to Present at Noble Capital Markets’ NobleCon20 on December 4, 2024

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Support SeaStar Medical’s Proposals to Ratify the Issuance of Shares and to Reduce the Number of Authorized Shares
ICU

GlobeNewswire

3 months ago

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Support SeaStar Medical’s Proposals to Ratify the Issuance of Shares and to Reduce the Number of Authorized Shares

SeaStar Medical Reaches Milestone of 100th QUELIMMUNE Commercial Device as Shipments Begin to its Third Hospital Customer
ICU

GlobeNewswire

3 months ago

SeaStar Medical Reaches Milestone of 100th QUELIMMUNE Commercial Device as Shipments Begin to its Third Hospital Customer

SeaStar Medical Reports Third Quarter 2024 Financial Results and Provides a Business Update
ICU

GlobeNewswire

3 months ago

SeaStar Medical Reports Third Quarter 2024 Financial Results and Provides a Business Update

FDA Grants Breakthrough Device Designation for SeaStar Medical’s Selective Cytopheretic Device for Adults Undergoing Chronic Dialysis
ICU

GlobeNewswire

4 months ago

FDA Grants Breakthrough Device Designation for SeaStar Medical’s Selective Cytopheretic Device for Adults Undergoing Chronic Dialysis

Record Monthly Enrollment Achieved in SeaStar Medical’s Pivotal Adult AKI Trial
ICU

GlobeNewswire

4 months ago

Record Monthly Enrollment Achieved in SeaStar Medical’s Pivotal Adult AKI Trial

SeaStar Medical Adds Second Hospital Customer for QUELIMMUNE
ICU

GlobeNewswire

4 months ago

SeaStar Medical Adds Second Hospital Customer for QUELIMMUNE

Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical’s QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 2024 - Update
ICU

GlobeNewswire

4 months ago

Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical’s QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 2024 - Update

Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical’s QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 2024
ICU

GlobeNewswire

4 months ago

Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical’s QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 2024

SeaStar Medical Announces that Stanford Medicine is Cleared to Actively Enroll Subjects in the Adult Acute Kidney Injury Pivotal Trial
ICU

GlobeNewswire

4 months ago

SeaStar Medical Announces that Stanford Medicine is Cleared to Actively Enroll Subjects in the Adult Acute Kidney Injury Pivotal Trial

SeaStar Medical to Distribute QUELIMMUNE Directly to Hospital Customers
ICU

GlobeNewswire

4 months ago

SeaStar Medical to Distribute QUELIMMUNE Directly to Hospital Customers

SeaStar hits halfway mark in AKI trial for selective cytopheretic device
ICU

Medical Device Network

4 months ago

SeaStar hits halfway mark in AKI trial for selective cytopheretic device

SeaStar Medical Announces that Enrollment in its Adult Acute Kidney Injury Pivotal Trial Has Exceeded the Halfway Point Toward an Interim Analysis
ICU

GlobeNewswire

4 months ago

SeaStar Medical Announces that Enrollment in its Adult Acute Kidney Injury Pivotal Trial Has Exceeded the Halfway Point Toward an Interim Analysis

SeaStar Medical to Showcase New Mechanistic Data Highlighting the Immunomodulatory Effect of the Selective Cytopheretic Device in Acute Kidney Injury at ASN Kidney Week
ICU

GlobeNewswire

4 months ago

SeaStar Medical to Showcase New Mechanistic Data Highlighting the Immunomodulatory Effect of the Selective Cytopheretic Device in Acute Kidney Injury at ASN Kidney Week

SeaStar Medical to Present at the 2024 Maxim Healthcare Virtual Summit
ICU

GlobeNewswire

4 months ago

SeaStar Medical to Present at the 2024 Maxim Healthcare Virtual Summit

SeaStar Medical Expands NEUTRALIZE-AKI Pivotal Trial Adding Two Premier Military Medical Facilities
ICU

GlobeNewswire

5 months ago

SeaStar Medical Expands NEUTRALIZE-AKI Pivotal Trial Adding Two Premier Military Medical Facilities

SeaStar Medical Reports Enrollment Momentum in Its Pivotal Adult AKI Trial
ICU

GlobeNewswire

5 months ago

SeaStar Medical Reports Enrollment Momentum in Its Pivotal Adult AKI Trial

SeaStar Medical to Webcast Fireside Chat at the H.C. Wainwright Global Investment Conference
ICU

GlobeNewswire

6 months ago

SeaStar Medical to Webcast Fireside Chat at the H.C. Wainwright Global Investment Conference

SeaStar Medical Strengthens Financial Position with Elimination of All Long-Term Debt
ICU

GlobeNewswire

6 months ago

SeaStar Medical Strengthens Financial Position with Elimination of All Long-Term Debt

ICU

MT Newswires

6 months ago

Top Premarket Decliners

SeaStar Medical Reports Second Quarter 2024 Financial Results and Provides a Business Update
ICU

GlobeNewswire

6 months ago

SeaStar Medical Reports Second Quarter 2024 Financial Results and Provides a Business Update

Nuwellis Announces First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical’s QUELIMMUNE™ Therapy at Cincinnati Children’s
ICU

GlobeNewswire

7 months ago

Nuwellis Announces First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical’s QUELIMMUNE™ Therapy at Cincinnati Children’s

ICU

MT Newswires

7 months ago

Sector Update: Health Care Stocks Edge Higher Late Afternoon

ICU

MT Newswires

7 months ago

Sector Update: Health Care Stocks Advance in Afternoon Trading

ICU

MT Newswires

7 months ago

SeaStar Medical Treats First Pediatric Patient in Commercial Setting With Kidney Drug

First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical’s FDA-Approved QUELIMMUNE Therapeutic Device
ICU

GlobeNewswire

7 months ago

First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical’s FDA-Approved QUELIMMUNE Therapeutic Device

Nuwellis Marks First Commercial Sale of QUELIMMUNE™ Therapy to Cincinnati Children’s
ICU

GlobeNewswire

7 months ago

Nuwellis Marks First Commercial Sale of QUELIMMUNE™ Therapy to Cincinnati Children’s

CMS Grants Category B Coverage for Adults with Acute Kidney Injury Enrolled in SeaStar Medical’s Selective Cytopheretic Device Pivotal Trial
ICU

GlobeNewswire

7 months ago

CMS Grants Category B Coverage for Adults with Acute Kidney Injury Enrolled in SeaStar Medical’s Selective Cytopheretic Device Pivotal Trial

ICU

MT Newswires

7 months ago

Sector Update: Health Care

ICU

MT Newswires

7 months ago

SeaStar Medical Begins Commercial Sale of Pediatric Acute Kidney Injury Treatment

SeaStar Medical Ships First QUELIMMUNE Product Order to U.S. Distribution Partner
ICU

GlobeNewswire

7 months ago

SeaStar Medical Ships First QUELIMMUNE Product Order to U.S. Distribution Partner

SeaStar Medical Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
ICU

GlobeNewswire

7 months ago

SeaStar Medical Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

ICU

MT Newswires

7 months ago

Sector Update: Health Care Stocks Advance in Afternoon Trading

ICU

MT Newswires

7 months ago

SeaStar Medical Launching $10 Million Direct Offering -- Shares Fall

SeaStar Medical Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
ICU

GlobeNewswire

7 months ago

SeaStar Medical Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

ICU

MT Newswires

8 months ago

SeaStar Medical Says US FDA Agrees to Final Labeling for Quelimmune

SeaStar Medical Finalizes FDA Labeling Requirement for QUELIMMUNE, Paving the Way for First Commercial Sales as Humanitarian Use Device
ICU

GlobeNewswire

8 months ago

SeaStar Medical Finalizes FDA Labeling Requirement for QUELIMMUNE, Paving the Way for First Commercial Sales as Humanitarian Use Device

Presenting on the Emerging Growth Conference 72 Day 2 on June 13 Register Now
ICU

GlobeNewswire

8 months ago

Presenting on the Emerging Growth Conference 72 Day 2 on June 13 Register Now

SeaStar Medical’s Selective Cytopheretic Device Featured in Two Presentations at the 42nd Vicenza Course AKI-CRT-ECOS and Critical Care Nephrology
ICU

GlobeNewswire

8 months ago

SeaStar Medical’s Selective Cytopheretic Device Featured in Two Presentations at the 42nd Vicenza Course AKI-CRT-ECOS and Critical Care Nephrology

Presenting on the Emerging Growth Conference 72 Day 1 on June 12 Register Now
ICU

GlobeNewswire

8 months ago

Presenting on the Emerging Growth Conference 72 Day 1 on June 12 Register Now

SeaStar Medical Strengthens Board of Directors and Transitions to Commercial-Stage Company
ICU

GlobeNewswire

8 months ago

SeaStar Medical Strengthens Board of Directors and Transitions to Commercial-Stage Company

Article in Nature Scientific Reports Describes Mechanism of Action of SeaStar Medical’s Selective Cytopheretic Device in the Immunomodulation of Excessive Inflammation
ICU

GlobeNewswire

9 months ago

Article in Nature Scientific Reports Describes Mechanism of Action of SeaStar Medical’s Selective Cytopheretic Device in the Immunomodulation of Excessive Inflammation

SeaStar Medical to Present at the Virtual Emerging Growth Conference on June 12, 2024
ICU

GlobeNewswire

9 months ago

SeaStar Medical to Present at the Virtual Emerging Growth Conference on June 12, 2024

SeaStar Medical Announces 25-for-1 Reverse Stock Split
ICU

GlobeNewswire

9 months ago

SeaStar Medical Announces 25-for-1 Reverse Stock Split

Seastar touts positive case studies for selective cytopheretic device
ICU

Medical Device Network

9 months ago

Seastar touts positive case studies for selective cytopheretic device

Manuscript Published on Multiorgan Failure Patients Treated with SeaStar Medical’s Selective Cytopheretic Device Who Achieved Transplant Eligibility
ICU

GlobeNewswire

9 months ago

Manuscript Published on Multiorgan Failure Patients Treated with SeaStar Medical’s Selective Cytopheretic Device Who Achieved Transplant Eligibility

SeaStar Medical Reports First Quarter 2024 Financial Results and Provides a Business Update
ICU

GlobeNewswire

9 months ago

SeaStar Medical Reports First Quarter 2024 Financial Results and Provides a Business Update

SeaStar Medical Announces $3.6 Million NIH Grant Award to Study the Selective Cytopheretic Device in Adult Patients with Severe Chronic Heart Failure
ICU

GlobeNewswire

10 months ago

SeaStar Medical Announces $3.6 Million NIH Grant Award to Study the Selective Cytopheretic Device in Adult Patients with Severe Chronic Heart Failure

SeaStar Medical Reports 2023 Financial Results and Provides a Business Update
ICU

GlobeNewswire

10 months ago

SeaStar Medical Reports 2023 Financial Results and Provides a Business Update

SeaStar Medical to Present at the Noble Capital Markets’ Emerging Growth Virtual Healthcare Equity Conference
ICU

GlobeNewswire

10 months ago

SeaStar Medical to Present at the Noble Capital Markets’ Emerging Growth Virtual Healthcare Equity Conference

SeaStar Medical to Restate Financials, Sets Business Update Call for April 17
ICU

GlobeNewswire

a year ago

SeaStar Medical to Restate Financials, Sets Business Update Call for April 17

SeaStar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA-Approved in Pediatric Patients
ICU

GlobeNewswire

a year ago

SeaStar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA-Approved in Pediatric Patients

SeaStar Medical-Sponsored Symposium Featuring Experts Discussing Pediatric Acute Kidney Injury and the Selective Cytopheretic Device to be Webcast Live at AKI & CRRT 2024
ICU

GlobeNewswire

a year ago

SeaStar Medical-Sponsored Symposium Featuring Experts Discussing Pediatric Acute Kidney Injury and the Selective Cytopheretic Device to be Webcast Live at AKI & CRRT 2024

ICU

Thomson Reuters StreetEvents

a year ago

Q4 2023 Nuwellis Inc Earnings Call

Manuscript Discussing the Benefit of SeaStar Medical’s Selective Cytopheretic Device in Patients with Heart Failure and Hyperinflammation Published in European Journal of Heart Failure
ICU

GlobeNewswire

a year ago

Manuscript Discussing the Benefit of SeaStar Medical’s Selective Cytopheretic Device in Patients with Heart Failure and Hyperinflammation Published in European Journal of Heart Failure

Nuwellis’ Distribution Partner, SeaStar Medical, Receives FDA Humanitarian Device Exemption for Pediatric Selective Cytopheretic Device Quelimmune™
ICU

GlobeNewswire

a year ago

Nuwellis’ Distribution Partner, SeaStar Medical, Receives FDA Humanitarian Device Exemption for Pediatric Selective Cytopheretic Device Quelimmune™

FDA Grants Humanitarian Device Exemption Approval to SeaStar Medical’s Selective Cytopheretic Device for Pediatric Acute Kidney Injury
ICU

GlobeNewswire

a year ago

FDA Grants Humanitarian Device Exemption Approval to SeaStar Medical’s Selective Cytopheretic Device for Pediatric Acute Kidney Injury

Unleash Massive Returns With These 3 Top Penny Stocks
ICU

InvestorPlace

a year ago

Unleash Massive Returns With These 3 Top Penny Stocks

SeaStar Medical Granted Canadian Patent with Broad Claims Covering the Selective Cytopheretic Device Technology
ICU

GlobeNewswire

a year ago

SeaStar Medical Granted Canadian Patent with Broad Claims Covering the Selective Cytopheretic Device Technology

SeaStar Medical Announces Pricing of $9.0 Million Registered Direct Offering Priced At-the-Market
ICU

GlobeNewswire

a year ago

SeaStar Medical Announces Pricing of $9.0 Million Registered Direct Offering Priced At-the-Market

It Might Not Be A Great Idea To Buy Ames National Corporation (NASDAQ:ATLO) For Its Next Dividend
ICU

Simply Wall St.

a year ago

It Might Not Be A Great Idea To Buy Ames National Corporation (NASDAQ:ATLO) For Its Next Dividend

AI Ascending: 3 Under-the-Radar Tech Stocks Poised for Explosive Growth
ICU

InvestorPlace

a year ago

AI Ascending: 3 Under-the-Radar Tech Stocks Poised for Explosive Growth

IceCure Medical's ProSense® Featured at Indian Society of Vascular and Interventional Radiology Conference: Key Opinion Leaders Highlight Benefits of Cryoablation
ICU

PR Newswire

a year ago

IceCure Medical's ProSense® Featured at Indian Society of Vascular and Interventional Radiology Conference: Key Opinion Leaders Highlight Benefits of Cryoablation

SeaStar Medical Appoints David A. Green as Chief Financial Officer
ICU

GlobeNewswire

a year ago

SeaStar Medical Appoints David A. Green as Chief Financial Officer

Why Fast-paced Mover Fathom Holdings (FTHM) Is a Great Choice for Value Investors
ICU

Zacks

a year ago

Why Fast-paced Mover Fathom Holdings (FTHM) Is a Great Choice for Value Investors

SKYX Will Debut Its New Patented Game-Changing Smart Home Platforms Technologies at CES 2024 - Opening Today, January 9th in Las Vegas
ICU

ACCESSWIRE

a year ago

SKYX Will Debut Its New Patented Game-Changing Smart Home Platforms Technologies at CES 2024 - Opening Today, January 9th in Las Vegas

SeaStar Medical Issued U.S. Patent with Broad Claims Covering Use of the Selective Cytopheretic Device for Multiple Clinical Indications
ICU

GlobeNewswire

a year ago

SeaStar Medical Issued U.S. Patent with Broad Claims Covering Use of the Selective Cytopheretic Device for Multiple Clinical Indications

TLSA: First Phase II SPMS Patient Dosed
ICU

Zacks Small Cap Research

a year ago

TLSA: First Phase II SPMS Patient Dosed

ProMIS Neurosciences Issues Letter to Shareholders
ICU

GlobeNewswire

a year ago

ProMIS Neurosciences Issues Letter to Shareholders

Dave Announces Repurchase of $100 million Convertible Note from FTX for $71 million
ICU

PR Newswire

a year ago

Dave Announces Repurchase of $100 million Convertible Note from FTX for $71 million

SeaStar Medical Updates Subject Enrollment in its Pivotal Trial with the Selective Cytopheretic Device in Adults with Acute Kidney Injury
ICU

GlobeNewswire

a year ago

SeaStar Medical Updates Subject Enrollment in its Pivotal Trial with the Selective Cytopheretic Device in Adults with Acute Kidney Injury

Velo3D, Inc. Announces $18 Million Registered Direct Offering
ICU

Business Wire

a year ago

Velo3D, Inc. Announces $18 Million Registered Direct Offering

Karuna downgraded, Arm target raised: Wall Street's top analyst calls
ICU

The Fly

a year ago

Karuna downgraded, Arm target raised: Wall Street's top analyst calls

A Look At The Intrinsic Value Of AMREP Corporation (NYSE:AXR)
ICU

Simply Wall St.

a year ago

A Look At The Intrinsic Value Of AMREP Corporation (NYSE:AXR)

7 Penny Stocks to Turn $100,000 Into $1 Million: December 2023
ICU

InvestorPlace

a year ago

7 Penny Stocks to Turn $100,000 Into $1 Million: December 2023

SeaStar Medical Forms Scientific Advisory Board of World-Renowned Pediatric and Adult Clinical Experts
ICU

GlobeNewswire

a year ago

SeaStar Medical Forms Scientific Advisory Board of World-Renowned Pediatric and Adult Clinical Experts

Urban One Inc (UONE) Reports Mixed Results for First and Second Quarters of 2023
ICU

GuruFocus.com

a year ago

Urban One Inc (UONE) Reports Mixed Results for First and Second Quarters of 2023

3 Underperforming Aluminum Stocks You Better Not Be Buying
ICU

InvestorPlace

a year ago

3 Underperforming Aluminum Stocks You Better Not Be Buying

ICU

Thomson Reuters StreetEvents

a year ago

Q1 2024 Comtech Telecommunications Corp Earnings Call

Lightbridge CEO Seth Grae to be Interviewed on BNN Bloomberg Tomorrow at 8:30am ET
ICU

GlobeNewswire

a year ago

Lightbridge CEO Seth Grae to be Interviewed on BNN Bloomberg Tomorrow at 8:30am ET

Provident Financial Holdings Announces CFO Succession
ICU

GlobeNewswire

a year ago

Provident Financial Holdings Announces CFO Succession

Foghorn Therapeutics Inc.'s (NASDAQ:FHTX) Price Is Right But Growth Is Lacking After Shares Rocket 27%
ICU

Simply Wall St.

a year ago

Foghorn Therapeutics Inc.'s (NASDAQ:FHTX) Price Is Right But Growth Is Lacking After Shares Rocket 27%

Those who invested in Manitex International (NASDAQ:MNTX) three years ago are up 42%
ICU

Simply Wall St.

a year ago

Those who invested in Manitex International (NASDAQ:MNTX) three years ago are up 42%

Eltek receives five purchase orders totaling $3.8 million
ICU

PR Newswire

a year ago

Eltek receives five purchase orders totaling $3.8 million

Just Three Days Till Kelly Services, Inc. (NASDAQ:KELY.A) Will Be Trading Ex-Dividend
ICU

Simply Wall St.

a year ago

Just Three Days Till Kelly Services, Inc. (NASDAQ:KELY.A) Will Be Trading Ex-Dividend

B. Riley Financial, Inc. Bolsters Position in Babcock & Wilcox Enterprises Inc
ICU

GuruFocus.com

a year ago

B. Riley Financial, Inc. Bolsters Position in Babcock & Wilcox Enterprises Inc

Bakkt Announces Relaunch of Bakkt® Custody with Additional Functionality and Expanded Asset Support
ICU

Business Wire

a year ago

Bakkt Announces Relaunch of Bakkt® Custody with Additional Functionality and Expanded Asset Support

Share on Social Networks: